A cytosolic protein was purified from Escherichia coli BL21 that demonstrated potent antifungal activity against pathogenic strains of Aspergillus fumigatus, Aspergillus flavus, Aspergillus niger and Candida albicans. The MIC of purified protein from E. coli BL21 (PPEBL21) against Aspergillus species and C. albicans was 1.95–3.98 and 15.62 μg ml−1, respectively. In vitro toxicity tests demonstrated no cytotoxicity of PPEBL21 to human erythrocytes up to the tested concentrations of 1250 μg ml−1. Amphotericin B was lethal to 100 % of human erythrocytes at a concentration of 37.5 μg ml−1. The N-terminal amino acid sequence of PPEBL21 was found to be DLAEVASR, which showed 75 % sequence similarity with alcohol dehydrogenase of yeast. Mass fingerprinting by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry also substantiated these observations. The results suggested that E. coli BL21 might be an important bioresource of lead molecules for developing new peptide-based therapies for treating fungal infections.
AntoineE.,
RollandJ.-H.,
RaffinJ.-P.,
DietrichJ.1999; Cloning and over-expression in Escherichia coli of the gene encoding NADPH group III alcohol dehydrogenase from Thermococcus hydrothermalis
. Eur J Biochem 264:880–889[CrossRef]
CammueB. P. A.,
De BolleM. F. C.,
TerrasF. R. G.,
ProostP.,
DammeJ. V.,
ReesS. B.,
VanderleydenJ.,
BroaekaertW. F.1992; Isolation and characterization of a novel class of plant antimicrobial peptide from Mirabilis jalapa L. seeds. J Biol Chem 267:2228–2233
DaburR.,
ChhillarA. K.,
YadavV.,
KamalP. K.,
GuptaJ.,
SharmaG. L.2005; In vitro antifungal activity of 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate, a dihydropyrrole derivative. J Med Microbiol 54:549–552[CrossRef]
GalgoczyL.,
PappT.,
LeiterE.,
MarxF.,
PocsiI.,
VagvolgyiC.2005; Sensitivity of different zygomycetes to the Penicillium chrysogenum antifungal protein (PAF. J Basic Microbiol 45:136–141[CrossRef]
GaoW. D.,
CaoH. T.,
JiR. H.,
ZhangZ. C.1994; Isolation and characterization of protein-biosynthesis inhibiting proteins from seeds of luffa cylindrica. Acta Biochim Biophys 26:289–295
IijimaR.,
KurataS.,
NatoriS.1993; Purification, characterization, and cDNA cloning of an antifungal protein from hemolymph of Sarcophaga peregrina (flesh fly) larvae. J Biol Chem 268:12055–12061
LatoudC.,
PeypouxF.,
MichelG.,
GenetR.,
MorgatJ.1986; Interactions of antibiotics of the iturin group with human erythrocytes. Biochim Biophys Acta 856:526–535[CrossRef]
LavermicoccaP.,
ValerioF.,
EvidenteA.,
LazzaroniS.,
CorsettiA.,
GobbettiM.2000; Purification and characterization of novel antifungal compounds from the sourdough Lactobacillus plantarum strain 21B. Appl Environ Microbiol 66:4084–4090[CrossRef]
LeiterE.,
SzappanosH.,
OberparleiterC.,
KaisererL.,
CsernochL.,
PusztahelyiT.,
EmriT.,
PocsiI.,
SalvenmoserW.,
MarxF.2005; Antifungal protein PAF severely affects the integrity of the plasma membrane of Aspergillus nidulans and induces an apoptosis-like phenotype. Antimicrob Agents Chemother 49:2445–2453[CrossRef]
Lodinová-ZádníkováR.,
CukrowskaB.,
Tlaskalova-HogenovaH.2003; Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years. Int Arch Allergy Immunol 131:209–211[CrossRef]
RoessnerC. A.,
ScottA. I.1996; Genetically engineered synthesis of natural products: from alkaloids to corrins. Annu Rev Microbiol 50:467–490[CrossRef]
RuchelR.,
PerskeC.,
GlassB.,
BaseckeJ.2006; A case of pulmonary aspergillosis with lack of response to caspofungin. Rev Iberoam Micol 23:94–96[CrossRef]
SchelenzS.,
RossC. N.2006; Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection. BMC Infect Dis 6:126[CrossRef]
Sims-McCallumR. P.2003; Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient. Am J Health Syst Pharm 60:2352–2356
SmithP. K.,
KrohnR. I.,
HermansonG. T.,
MalliaA. K.,
GartnerF. H.,
ProvenzanoM. D.,
FujimotoE. K.,
GoekeN. M.,
OlsonB. J.,
KlenkD. C.1985; Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85[CrossRef]
ThompsonJ. D.,
HigginsD. G.,
GibsonT. J.1994; clustal w: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680[CrossRef]
WegnerB.,
BaerP.,
GauerS.,
OremekG.,
HauserI. A.,
GeigerH.2005; Caspofungin is less nephrotoxic than amphotericin B in vitro and predominantly damages distal renal tubular cells. Nephrol Dial Transplant 20:2071–2079[CrossRef]
WooJ. H.,
KitamuraE.,
MyuogaH.,
YutoK.2002; An antifungal protein from the marine bacterium Streptomyces sp. strain AP77 is specific for Pythium porphyrae , a causative agent of red rot disease in Porphyra spp. Appl Environ Microbiol 68:2666–2675[CrossRef]
YadavV.,
MandhanR.,
DaburR.,
ChhillarA. K.,
GuptaJ.,
SharmaG. L.2005; An antifungal fraction from Escherichia coli
. J Med Microbiol 54:375–379[CrossRef]